Hand's Pick
Big Pharma Shakeup: Neurocrine Buys Soleno for Breakthrough Hunger Drug
Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a major move that could reshape its future, Neurocrine Biosciences has announced it will acquire Soleno Therapeutics for $2.9…
Latest News
Forget AI! It’s Human Innovation That Will Rule the Future
Forget AI! It’s Human Innovation That Will Rule the Future The Future of Growth: Human Innovation vs. Technology While the…
Oracle’s AI Bet Backfires? Stock Suffers Historic Drop as Wall Street Grows Nervous
Oracle Stock Suffers Its Worst Quarter in Over Two Decades Oracle is heading toward one of the darkest quarters in…
FirstCry: Your One-Stop Shop for All Your Baby and Kids Needs
Parenthood is a beautiful journey filled with love, joy, and an array of responsibilities. Among these responsibilities, ensuring that your…
Lower Crude Prices Force BP to Pause Buybacks Despite Steady Q4 Profits
British energy giant BP has announced the suspension of its share buyback program, signaling growing pressure from lower oil prices…
